The first time this kind of itching showed up — dry, persistent, appearing on the inner arms and neck out of nowhere — the assumption was an allergy to something new. Months of elimination diets and patch tests later, the real culprit turned out to be hormones the whole time. If your skin has suddenly turned against you and nothing topical seems to fix it for long, it is worth knowing that this particular pattern has a name, a mechanism, and a reason.
Learn more about Rose →Estrogen receptors are present throughout the epidermis and actively regulate the production of filaggrin and ceramides — two proteins essential for a sealed, functional skin barrier. As estrogen falls in perimenopause, filaggrin expression decreases, leaving gaps in the outermost skin layer that allow irritants and allergens to penetrate more easily and moisture to escape. This structural breakdown is one of the most direct mechanisms linking hormonal change to eczema onset, and it explains why the condition appears systemically rather than in one contact-exposed area.
Mast cells — immune cells embedded in skin tissue that release histamine and inflammatory chemicals — are directly modulated by estrogen and progesterone. Research shows that estrogen can both prime and sensitise mast cells, and that the erratic hormonal fluctuations of perimenopause, rather than simply low estrogen, may trigger exaggerated mast cell responses that manifest as itching, flushing, hives, or eczema-like inflammation. This is why symptoms can be wildly inconsistent day to day: the mast cell response is following the hormonal signal, not a consistent external allergen.
Healthy skin holds moisture partly because estrogen stimulates the production of hyaluronic acid and supports the lipid matrix between skin cells that acts as a physical seal. When estrogen declines, transepidermal water loss (TEWL) increases measurably — the skin dries out from within, not just on the surface, and this chronic dryness is itself an inflammatory state. Skin in this condition is primed for eczema flares because the itch-scratch cycle can begin without any external trigger at all.
Estrogen has complex immunomodulatory effects, and one of its roles is partially suppressing Th2-dominant immune responses — the type associated with allergic and atopic conditions including eczema and asthma. As estrogen levels become erratic and eventually lower, this immune balance can tip toward increased Th2 activity, raising the inflammatory baseline of the skin. Women who had subclinical atopic tendencies their whole lives may find that this immune shift is enough to push them over the threshold into visible, symptomatic eczema for the first time.
Disrupted sleep, hot flashes, and chronic low-grade stress during perimenopause all drive elevated or dysregulated cortisol output, and chronically elevated cortisol is independently associated with worsened atopic dermatitis through multiple pathways including increased skin permeability and altered immune signalling. The skin has its own local hypothalamic-pituitary-adrenal (HPA) axis and produces cortisol locally in response to stress signals, which means the inflammatory cascade can be driven from within the skin tissue itself. This is why stress and poor sleep in perimenopause tend to worsen eczema symptoms measurably and reliably.
A balanced skin microbiome — dominated by commensal bacteria like Staphylococcus epidermidis — actively protects against inflammation and pathogenic colonisation. Estrogen influences skin pH and sebum production, both of which shape which microorganisms can thrive on the skin's surface, and postmenopausal skin shows measurable shifts toward a less diverse microbiome. Staphylococcus aureus, which is strongly associated with eczema flares and barrier disruption, is more likely to colonise skin that has shifted toward a higher pH — which is precisely what happens when estrogen falls.
While estrogen gets most of the attention, testosterone and DHEA also decline significantly during the menopause transition, and these androgens directly stimulate sebaceous gland activity — the skin's own moisturising system. Reduced sebum output leaves the skin more vulnerable to environmental irritants, cold air, and detergents that would previously have been managed by the skin's natural oils. For women with any inherited tendency toward dry or sensitive skin, this reduction in sebum can be the tipping point that transforms a manageable predisposition into a diagnosable condition.
Estrogen plays a role in regulating the density and sensitivity of cutaneous nerve fibres — the nerve endings in skin responsible for detecting itch and pain signals. As estrogen declines, research indicates that skin can become hyperinnervated in some regions or that existing nerve fibres become more reactive, amplifying the itch sensation beyond what the degree of visible inflammation would predict. This explains the clinical pattern many women describe: intense, persistent itching on skin that looks only mildly affected or even normal to the eye.
Many women in perimenopause notice they are suddenly reacting to skincare products, laundry detergents, or fabrics they have used for years without issue — and assume contact dermatitis is the primary diagnosis. While contact sensitisation can increase with age, the more accurate picture is that a compromised skin barrier allows previously manageable irritants to penetrate and trigger a response that the intact skin would have blocked entirely. Treating the barrier dysfunction driven by hormonal change — rather than only eliminating individual products — is the more fundamental intervention, and one worth discussing with a dermatologist who understands the menopause context.
Rose covers every symptom, supplement, and condition in full detail — evidence-graded and agenda-free.
Rose is a free, evidence-based reference built for women navigating perimenopause and menopause. No ads. No products to sell. No agenda. Just honest answers — because every woman in this season deserves a trusted friend who has done the research.